Dr. Leticia Tornes, MD

Dr. Tornes practices at UMiami Medicine - Neurology in Miami, Florida.

Dr. Tornes' NPI, 1922201623, was assigned on June 8, 2007. Dr. Tornes graduated from University of Miami, Miller School of Medicine in 2006. Dr. Tornes holds Florida license ME108307.

Dr. Tornes' primary practice is UMiami Medicine - Neurology, at 1150 Nw 14th St, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-4951.

Dr. Tornes' primary practice is UMiami Medicine - Neurology in Miami, Florida. Dr. Tornes is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Tornes to 1 more group practice or clinic, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tornes practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Tornes' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Tornes is board certified in epilepsy by the American Board of Psychiatry and Neurology. Dr. Tornes is licensed in Florida.

Dmand AI lists multiple sclerosis among the conditions Dr. Tornes treats.

CMS data shows 29 Medicare services from Dr. Tornes across 1 procedure code in 2024, all of them office visits, for 30 Medicare patients. Medicare paid $4,203 for them. Every service was in an office.

CMS counts 30 Medicare patients who saw Dr. Tornes in 2024. The largest group is under 65, with 18 patients. 60% of them have high cholesterol, and 57% have high blood pressure. 43% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tornes' median patient age at 54, with 72% women.

In 2024, Dr. Tornes wrote 823 Medicare Part D claims for 76 patients. 86% of them were for generic drugs. CMS names the drug for 639 of them, across 26 drugs with 11 or more claims each, at $341,290 in total drug cost. In 2023, CMS named 697 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Tornes for performance year 2024, reported as part of a group. Dr. Tornes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tornes as offering telehealth.

Dmand AI links 24 papers to Dr. Tornes, published from 2010 to 2024. 2021 was the busiest year, with 5. The most frequent topics are Multiple Sclerosis, Pulmonary Artery and Spinal Cord. Dr. Tornes has published most often in Mult Scler Relat Disord. Dr. Tornes' most frequent co-authors are Jason Margolesky, MD, Silvia R. Delgado and Kottil W. Rammohan, MD.

Dmand AI links Dr. Tornes to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Multiple Sclerosis, Fatigue and Multiple Sclerosis, Relapsing-Remitting.

CMS Open Payments shows 202 general payments to Dr. Tornes from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 59% of the total. Biogen, Inc. paid the most, $9,713.

Dmand AI lists 1 award for Dr. Tornes, most recently CMS Stage 1 EHR in 2013.

Dr. Tornes graduated from University of Miami, Miller School of Medicine in 2006. Dr. Tornes is a member of AAN.

Dr. Tornes is in network with 9 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Molina. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.